Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients with Venous Thromboembolism in Europe - ETNA-VTE-Europe

Trial Profile

Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients with Venous Thromboembolism in Europe - ETNA-VTE-Europe

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2017

At a glance

  • Drugs Edoxaban (Primary)
  • Indications Venous thromboembolism
  • Focus Adverse reactions
  • Acronyms ETNA-VTE; ETNA-VTE-Europe
  • Sponsors Daiichi Sankyo Europe; Daiichi Sankyo Inc
  • Most Recent Events

    • 15 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top